Global Liquid Biopsy Market Overview:
Global Liquid Biopsy Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2025-2032, Considering the Base Year As 2024.
Global Liquid Biopsy Market Report 2025 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of Liquid Biopsy involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Liquid Biopsy Market:
The Liquid Biopsy Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Liquid Biopsy Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Liquid Biopsy Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Liquid Biopsy market has been segmented into:
Assay Kits
Instruments
Services
By Application, Liquid Biopsy market has been segmented into:
Multi Gene Parallel Analysis
Single Gene Analysis
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Liquid Biopsy market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Liquid Biopsy market.
Top Key Players Covered in Liquid Biopsy market are:
Apostle Inc
Biocept Inc.
BioChain Institute Inc.
Biolidics Ltd.
CatchGene
Elphogene
F. Hoffmann-La Roche AG
Gencurix Inc.
Genomill Health
Guardant Health Inc.
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Liquid Biopsy Market Type
4.1 Liquid Biopsy Market Snapshot and Growth Engine
4.2 Liquid Biopsy Market Overview
4.3 Assay Kits
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Assay Kits: Geographic Segmentation Analysis
4.4 Instruments
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Instruments: Geographic Segmentation Analysis
4.5 Services
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Services: Geographic Segmentation Analysis
Chapter 5: Liquid Biopsy Market Application
5.1 Liquid Biopsy Market Snapshot and Growth Engine
5.2 Liquid Biopsy Market Overview
5.3 Multi Gene Parallel Analysis
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Multi Gene Parallel Analysis: Geographic Segmentation Analysis
5.4 Single Gene Analysis
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Single Gene Analysis: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Liquid Biopsy Market Share by Manufacturer (2025)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 APOSTLE INC; BIOCEPT
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 INC.; BIOCHAIN INSTITUTE
6.4 INC.; BIOLIDICS LTD.; CATCHGENE; ELPHOGENE; F. HOFFMANN-LA ROCHE AG; GENCURIX
6.5 INC.; GENOMILL HEALTH; GUARDANT HEALTH
6.6 INC.
Chapter 7: Global Liquid Biopsy Market By Region
7.1 Overview
7.2. North America Liquid Biopsy Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 Assay Kits
7.2.2.2 Instruments
7.2.2.3 Services
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 Multi Gene Parallel Analysis
7.2.3.2 Single Gene Analysis
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Liquid Biopsy Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 Assay Kits
7.3.2.2 Instruments
7.3.2.3 Services
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 Multi Gene Parallel Analysis
7.3.3.2 Single Gene Analysis
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Liquid Biopsy Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 Assay Kits
7.4.2.2 Instruments
7.4.2.3 Services
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 Multi Gene Parallel Analysis
7.4.3.2 Single Gene Analysis
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Liquid Biopsy Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 Assay Kits
7.5.2.2 Instruments
7.5.2.3 Services
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 Multi Gene Parallel Analysis
7.5.3.2 Single Gene Analysis
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Liquid Biopsy Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 Assay Kits
7.6.2.2 Instruments
7.6.2.3 Services
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 Multi Gene Parallel Analysis
7.6.3.2 Single Gene Analysis
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Liquid Biopsy Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 Assay Kits
7.7.2.2 Instruments
7.7.2.3 Services
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 Multi Gene Parallel Analysis
7.7.3.2 Single Gene Analysis
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Liquid Biopsy Scope:
|
Report Data
|
Liquid Biopsy Market
|
|
Liquid Biopsy Market Size in 2025
|
USD XX million
|
|
Liquid Biopsy CAGR 2025 - 2032
|
XX%
|
|
Liquid Biopsy Base Year
|
2024
|
|
Liquid Biopsy Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Apostle Inc, Biocept Inc., BioChain Institute Inc., Biolidics Ltd., CatchGene, Elphogene, F. Hoffmann-La Roche AG, Gencurix Inc., Genomill Health, Guardant Health Inc..
|
|
Key Segments
|
By Type
Assay Kits
Instruments
Services
By Applications
Multi Gene Parallel Analysis
Single Gene Analysis
|
